National Bank of Canada
SYRS

National Bank of Canada’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

National Bank of Canada’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-859
Closed -$4.23K – 2868
2024
Q2 		$4.23K Buy
+859
New +$4.23K ﹤0.01% 2145